Table 2.
Probe sets that indicate increased gene expression in orbital adipose with fibrosis.
| Probe Set | Gene Title | Fold Change* | FDR p-value |
|---|---|---|---|
| 243085_at | --- | 1.2181 | 0.0374 |
|
| |||
| 224694_at | anthrax toxin receptor 1 | 1.3928 | 0.0016 |
| 220092_s_at | 1.2915 | 0.0310 | |
|
| |||
| 202965_s_at | calpain 6 | 1.4451 | 0.0406 |
|
| |||
| 224619_at | cancer susceptibility candidate 4 | 1.1945 | 0.0449 |
|
| |||
| 207173_x_at | cadherin 11, type 2, OB-cadherin (osteoblast) | 1.4538 | 0.0014 |
| 207172_s_at | 1.3217 | 0.0100 | |
|
| |||
| 202404_s_at | collagen, type I, alpha 2 | 1.5119 | 0.0016 |
|
| |||
| 221900_at | collagen, type VIII, alpha 2 | 1.3230 | 0.0098 |
|
| |||
| 225681_at | collagen triple helix repeat containing 1 | 1.5247 | 0.0265 |
|
| |||
| 232343_at | dynactin 5 (p25) | 1.1912 | 0.0252 |
|
| |||
| 213853_at | DnaJ (Hsp40) homolog, subfamily C, member 24 | 1.2404 | 0.0450 |
|
| |||
| 201430_s_at | dihydropyrimidinase-like 3 | 1.2101 | 0.0406 |
|
| |||
| 212231_at | F-box protein 21 | 1.1767 | 0.0494 |
|
| |||
| 212464_s_at | fibronectin 1 | 1.5643 | 0.0015 |
| 211719_x_at | 1.5108 | 0.0016 | |
| 216442_x_at | 1.5068 | 0.0016 | |
| 210495_x_at | 1.4716 | 0.0036 | |
| 214701_s_at | 1.4095 | 0.0077 | |
|
| |||
| 226930_at | fibronectin type III domain containing 1 | 1.6789 | 0.0406 |
|
| |||
| 209524_at | hepatoma-derived growth factor, related protein 3 | 1.2324 | 0.0406 |
|
| |||
| 211868_x_at | immunoglobulin (IgG) heavy locus; IgG heavy constant alpha 1; IgG heavy constant alpha 2 (A2m marker); IgG heavy constant delta; IgG heavy constant gamma 1 (G1m marker); IgG heavy constant gamma 2 (G2m marker); IgG heavy constant gamma 3 (G3m marker); IgG heavy constant mu; IgG heavy variable 4–31 | 1.2907 | 0.0406 |
|
| |||
| 211635_x_at | IgG heavy constant alpha 1; IgG heavy constant alpha 2 (A2m marker); IgG heavy constant delta; IgG heavy constant gamma 1 (G1m marker); IgG heavy constant gamma 3 (G3m marker); IgG heavy constant gamma 4 (G4m marker); IgG heavy constant mu; IgG heavy variable 4–31 | 1.4915 | 0.0252 |
|
| |||
| 211640_x_at | IgG heavy constant gamma 1 (G1m marker); IgG heavy constant mu | 1.5036 | 0.0415 |
| 216541_x_at | 1.4027 | 0.0406 | |
| 211647_x_at | 1.3756 | 0.0382 | |
|
| |||
| 216853_x_at | IgG lambda variable 3–19; NULL | 1.4989 | 0.0265 |
|
| |||
| 201744_s_at | lumican | 1.6664 | 0.0006 |
|
| |||
| 218729_at | latexin | 1.3505 | 0.0489 |
|
| |||
| 37005_at | MINOS1-NBL1 readthrough; neuroblastoma 1, DAN family BMP antagonist | 1.2373 | 0.0016 |
|
| |||
| 201621_at | neuroblastoma 1, DAN family BMP antagonist | 1.2149 | 0.0098 |
|
| |||
| 1554591_at | prostate cancer associated transcript 4 (non-protein coding) | 1.2300 | 0.0277 |
|
| |||
| 227276_at | plexin domain containing 2 | 1.2265 | 0.0406 |
|
| |||
| 204517_at | peptidylprolyl isomerase C (cyclophilin C) | 1.2210 | 0.0449 |
|
| |||
| 211737_x_at | pleiotrophin | 1.4403 | 0.0098 |
| 209466_x_at | 1.3701 | 0.0449 | |
|
| |||
| 224901_at | stearoyl-CoA desaturase 5 | 1.2773 | 0.0277 |
|
| |||
| 228844_at | solute carrier family 13 (sodium-dependent citrate transporter), member 5 | 1.2062 | 0.0449 |
|
| |||
| 212354_at | sulfatase 1 | 1.3868 | 0.0449 |
|
| |||
| 201107_s_at | thrombospondin 1 | 1.4172 | 0.0252 |
| 201108_s_at | 0.0406 | ||
| 201109_s_at | 0.0449 | ||
|
| |||
| 201666_at | TIMP metallopeptidase inhibitor 1 | 1.2909 | 0.0406 |
|
| |||
| 210986_s_at | tropomyosin 1 (alpha) | 1.2643 | 0.0491 |
|
| |||
| 1553718_at | zinc finger protein 548 | 1.2220 | 0.0449 |
*
Based on a linear trend